Clarient licenses potential cancer testing technology from Minerva BiotechnologiesValeant says it began shipping authorized generic version of irritable bowel drug Librax
Valeant Pharma begins selling generic IBS drug Avanir Pharma says higher dose of Zenvia reduced number of emotional outbursts tied to diseaseAvanir posts mixed late stage Zenvia study results ALISO VIEJO, Calif. — Avanir Pharmaceuticals Inc. on Friday reported mixed results for its drug candidate Zenvia, which is intended to reduce involuntary emotional outbursts in patients with neurological disorders. |